Loading organizations...
§ Private Profile · Louisville, KY, USA
Research and development of patented vaccine technology.
TNG Pharmaceuticals has raised $4.6M across 1 funding round.
TNG Pharmaceuticals has raised $4.6M in total across 1 funding round.
TNG Pharmaceuticals has raised $4.6M across 1 funding round. Most recently, it raised $4.6M Series A in February 2014.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 6, 2014 | $4.6M Series A | Yearling Fund | AIM Group, Blue Grass Angels, Commonwealth Seed Capital, Goose Capital, Ogle Foundation, Texas Halo Fund, University OF Louisville Foundation | Announced |
TNG Pharmaceuticals has raised $4.6M in total across 1 funding round.
TNG Pharmaceuticals's investors include Yearling Fund, AIM Group, Blue Grass Angels, Commonwealth Seed Capital, Goose Capital, Ogle Foundation, Texas Halo Fund, University of Louisville Foundation.